Author

Alvaro Ingles Garces

Royal Marsden NHS Foundation TrustORCID 0000-0002-0073-4237Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:simulation· 1

Frequent Co-Authors

Ahmet AcariD· 1 shared Andrea SottorivaiD· 1 shared Frederick J.H. WhitingiD· 1 shared Ioanna MavrommatiiD· 1 shared Rachael NatrajaniD· 1 shared Trevor A. GrahamiD· 1 shared Udai BanerjiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ahmet AcarORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inference of Cancer Drug Cross Resistance Using Only Single-Drug Exposure Data

Frederick J.H. Whiting, Ioanna Mavrommati, Ahmet Acar, Alvaro Ingles Garces, Udai Banerji, Andrea Sottoriva, Rachael Natrajan, Trevor A. Graham

This paper identifies cross resistance between cancer drugs using single-drug exposure data, showing that high cross resistance reduces the effectiveness of switching between CDK4/6 inhibitors.

bioRxiv · Mar 13, 2026 · PreprintCancer Biology